RNA Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of RNA, By Application, By Technique, By Region and Competition, 2020-2030F

Description

The Global RNA Editing Technologies Market, valued at USD 262.28 Million in 2024, is projected to experience a CAGR of 7.16% to reach USD 397.16 Million by 2030. RNA editing technologies involve molecular processes that precisely modify specific nucleotide sequences within an RNA molecule after its transcription, distinct from permanent alterations to the genomic DNA. This enables targeted corrections of genetic mutations and modulation of gene expression for therapeutic, research, and diagnostic applications. The market's expansion is fundamentally driven by the increasing demand for precision medicine, significant advancements in CRISPR-based RNA editing tools, and growing investments in RNA editing research.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 262.28 Million
Market Size 2030	USD 397.16 Million
CAGR 2025-2030	7.16%
Fastest Growing Segment	Messenger RNA Modification
Largest Market	North America

Key Market Drivers

The global RNA editing technologies market is profoundly influenced by two pivotal factors: significant advancements in RNA editing technologies and the increasing demand for precision and personalized medicine. Ongoing innovation in advanced gene editing platforms, particularly CRISPR-based systems and enhanced delivery mechanisms, continues to broaden the therapeutic applicability of RNA editing. For instance, according to the Innovative Genomics Institute, in March 2024, the UK's Medicines and Healthcare Products Regulatory Agency approved Casgevy for sickle cell disease and transfusion-dependent beta-thalassemia in November 2023, with subsequent FDA approval for sickle cell disease in December 2023, marking the first regulatory clearances for a CRISPR-based therapy.

Key Market Challenges

The technical complexity associated with efficient delivery and precise targeting systems for RNA editing components within specific cells and tissues represents a significant impediment to market expansion. This challenge directly affects the progression and success of therapeutic development by prolonging research and development timelines and escalating costs. The difficulty in developing safe and effective methods to introduce RNA editing tools precisely into target cells, without off-target effects or degradation, limits the scalability and broad application of these advanced therapies.

Key Market Trends

Increased cross-sectoral collaborations and partnerships are significantly driving growth in the Global RNA Editing Technologies Market by fostering shared expertise and resources. These alliances between biotechnology firms, pharmaceutical companies, and academic institutions accelerate the complex research and development cycle of RNA editing solutions. For example, in September 2024, Prime Medicine announced a strategic research collaboration and license agreement with Bristol Myers Squibb, which included a $55 million upfront payment and a $55 million equity investment, to develop ex vivo T-cell therapies using Prime Editing technology, demonstrating significant financial commitment to such joint ventures.

Key Market Players

ProQR Therapeutics NV
Sirna Therapeutics, Inc.
Shape Therapeutics, Inc.
Korro Bio, Inc.
Beam Therapeutics, Inc.
QIAGEN N.V.
UniQure NV (UniQure)
LAVA Therapeutics N.V.
argenx SE
Arrowhead Pharmaceuticals, Inc.

Report Scope:

In this report, the Global RNA Editing Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

RNA Editing Technologies Market, By Type of RNA:

Messenger RNA Modification
Transfer RNA Modification
Ribosomal RNA Modification

RNA Editing Technologies Market, By Application:

Cancer
Genetic Disorders
Temporary Maladies

RNA Editing Technologies Market, By Technique:

Insertion/Deletion
Deamination

RNA Editing Technologies Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global RNA Editing Technologies Market.

Available Customizations:

Global RNA Editing Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global RNA Editing Technologies Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type of RNA (Messenger RNA Modification, Transfer RNA Modification, Ribosomal RNA Modification)
- 5.2.2. By Application (Cancer, Genetic Disorders, Temporary Maladies)
- 5.2.3. By Technique (Insertion/Deletion, Deamination)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America RNA Editing Technologies Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type of RNA
- 6.2.2. By Application
- 6.2.3. By Technique
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States RNA Editing Technologies Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type of RNA
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By Technique
- 6.3.2. Canada RNA Editing Technologies Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type of RNA
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By Technique
- 6.3.3. Mexico RNA Editing Technologies Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type of RNA
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By Technique

7. Europe RNA Editing Technologies Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type of RNA
- 7.2.2. By Application
- 7.2.3. By Technique
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany RNA Editing Technologies Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type of RNA
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By Technique
- 7.3.2. France RNA Editing Technologies Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type of RNA
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By Technique
- 7.3.3. United Kingdom RNA Editing Technologies Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type of RNA
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By Technique
- 7.3.4. Italy RNA Editing Technologies Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type of RNA
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By Technique
- 7.3.5. Spain RNA Editing Technologies Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type of RNA
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By Technique

8. Asia Pacific RNA Editing Technologies Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type of RNA
- 8.2.2. By Application
- 8.2.3. By Technique
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China RNA Editing Technologies Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type of RNA
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By Technique
- 8.3.2. India RNA Editing Technologies Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type of RNA
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By Technique
- 8.3.3. Japan RNA Editing Technologies Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type of RNA
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By Technique
- 8.3.4. South Korea RNA Editing Technologies Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type of RNA
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By Technique
- 8.3.5. Australia RNA Editing Technologies Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type of RNA
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By Technique

9. Middle East & Africa RNA Editing Technologies Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type of RNA
- 9.2.2. By Application
- 9.2.3. By Technique
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia RNA Editing Technologies Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type of RNA
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By Technique
- 9.3.2. UAE RNA Editing Technologies Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type of RNA
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By Technique
- 9.3.3. South Africa RNA Editing Technologies Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type of RNA
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By Technique

10. South America RNA Editing Technologies Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type of RNA
- 10.2.2. By Application
- 10.2.3. By Technique
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil RNA Editing Technologies Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type of RNA
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By Technique
- 10.3.2. Colombia RNA Editing Technologies Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type of RNA
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By Technique
- 10.3.3. Argentina RNA Editing Technologies Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type of RNA
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By Technique

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global RNA Editing Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. ProQR Therapeutics NV
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Sirna Therapeutics, Inc.
15.3. Shape Therapeutics, Inc.
15.4. Korro Bio, Inc.
15.5. Beam Therapeutics, Inc.
15.6. QIAGEN N.V.
15.7. UniQure NV (UniQure)
15.8. LAVA Therapeutics N.V.
15.9. argenx SE
15.10. Arrowhead Pharmaceuticals, Inc.